Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma

Ann Surg. 1992 Feb;215(2):125-31. doi: 10.1097/00000658-199202000-00006.

Abstract

Thirty-four patients with subtotally resected or unresectable carcinoma of the extrahepatic bile ducts received radiation therapy; a minimum of 45 Gy (external beam) to the tumor and regional lymph nodes +/- 5-fluorouracil (5-FU). Seventeen patients received an external beam boost of 5 to 15 Gy to the tumor, and a specialized boost was used in the remaining 17 patients (iridium-192 transcatheter seeds in 10 and intraoperative radiation therapy [IORT] with electrons in seven). The median time to death in all 34 patients was 12 months (range, 4 to 98-months). The only patients who survived longer than 18 months were those either with gross total or subtotal resection before external irradiation (2 of 6) or who received specialized boosts (192Ir, 3 of 10; IORT, 3 of 7). Local failure was documented in 9 of 17 patients who received external beam irradiation alone +/- 5-FU, 3 of 10 patients who received an 192Ir boost, and 2 of 6 patients who received an IORT boost with curative intent.

MeSH terms

  • Adenoma, Bile Duct / drug therapy
  • Adenoma, Bile Duct / radiotherapy*
  • Adenoma, Bile Duct / surgery
  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms / drug therapy
  • Bile Duct Neoplasms / radiotherapy*
  • Bile Duct Neoplasms / surgery
  • Combined Modality Therapy
  • Dose-Response Relationship, Radiation
  • Female
  • Fluorouracil / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Radiotherapy / adverse effects
  • Radiotherapy / methods
  • Survival Analysis
  • Treatment Outcome

Substances

  • Fluorouracil